The neuropsychological performance of nondemented puerto rican nonagenarians

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 4, 2009, Pages 353-360

  Carrión Baralt, José R ^a,b,d   Meléndez Cabrero, Josefina ^a,b   Schnaider Beeri, Michal ^a   Sano, Mary ^a,c   Silverman, Jeremy M ^a,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b San Juan Veterans Affairs Medical Center   (Puerto Rico)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VA MEDICAL CENTER   (Puerto Rico)

Author keywords

Oldest old population; Puerto Rican nonagenarians; Successful cognitive aging

Indexed keywords

AGED; AGING; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; EDUCATION; FEMALE; GROUPS BY AGE; HUMAN; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PUERTO RICO; UNITED STATES;

AGED, 80 AND OVER; AGING; COGNITION; DEMENTIA; EDUCATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; LANGUAGE; MALE; MEMORY; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; NEW YORK CITY; PRACTICE (PSYCHOLOGY); PSYCHOMOTOR PERFORMANCE; RECOGNITION (PSYCHOLOGY); SEX FACTORS;

EID: 62049083599     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209213     Document Type: Article

References (24)

1. National Institute on Aging: Action plan for aging research: strategic plan for fiscal years 2001-2005. http://www.nia.nih.gov/About-NIA/StrategicPlan/ (accessed August 6, 2007).
2. Silverman JM, Smith CJ, Marin DB, Birstein S, Mare M, Mohs RC, Davis KL: Identifying families with likely genetic protective factors against Alzheimer's disease. Am J Hum Genet 1999;64:832-838.
3. Silverman JM, Schnaider-Beeri M, Grossman HT, Schmeidler J, Wang JY, Lally RC: A phenotype for genetic studies of successful cognitive aging. Am J Med Genet B Neuro-psychiatr Genet 2008;147B:16 7-173.
4. Alzheimer's Association: Research grants program announcement. Fiscal year 2007 (July 2007 - June 2008). 2007.
5. Corona-LoMonaco ME, Ponton MO, Her-rera LP, Gonzalez J, Herrera S: The impact of language and culture on a neuropsychological screening battery for Hispanics. Arch Clin Neuropsychol 1999;14:714.
6. Fillenbaum GG, McCurry SM, Kuchibhatla M, Masaki KH, Borenstein AR, Foley DJ, Heyman A, Larson EB, White L: Performance on the CERAD neuropsychology battery of two samples of Japanese-American elders: norms for persons with and without dementia. J Int Neuropsychol Soc 2005;11: 192-201.
7. Lee DY, Lee KU, Lee JH, Kim KW, Jhoo JH, Kim SY, Yoon JC, Woo SI, Ha J, Woo JI: A normative study of the CERAD neuropsy-chological assessment battery in the Korean elderly. J Int Neuropsychol Soc 2004;10:72- 81.
8. Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo Neto J, Ramos LR: Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr 2001;59:532-536.
9. Unverzagt FW, Morgan OS, Thesiger CH, Eldemire DA, Luseko J, Pokuri S, Hui SL, Hall KS, Hendrie HC: Clinical utility of CERAD neuropsychological battery in elderly Jamaicans. J Int Neuropsychol Soc 1999;5:255-259.
10. Morris JC: Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer's type. Int Psychogeriatr 1997; 9(suppl 1):173-178.
11. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The consortium to establish a registry for Alzheimer's disease (CERAD). 5. A normative study of the neuropsychological battery. Neurology 1994;44:609-614.
12. Aguirre-Acevedo DC, Gomez RD, Moreno S, Henao-Arboleda E, Motta M, Munoz C, Arana A, Pineda DA, Lopera F: Validity and reliability of the CERAD-col neuropsycho-logical battery. Rev Neurol 2007;45:655- 660.
13. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
14. Kaplan E, Goodglass H, Weintraub S: The Boston Naming Test. Philadelphia, Lea and Febiger, 1983.
15. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erl-baum, 1988.
16. Beeri MS, Schmeidler J, Sano M, Wang J, Lal-ly R, Grossman H, Silverman JM: Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old. Neurology 2006;67:1006-1010.
17. Collie A, Shafiq-Antonacci R, Maruff P, Tyler P, Currie J: Norms and the effects of demographic variables on a neuropsychologi-cal battery for use in healthy ageing Australian populations. Aust NZ J Psychiatry 1999;33:568-575.
18. McCurry SM, Gibbons LE, Uomoto JM, Thompson ML, Graves AB, Edland SD, Bowen J, McCormick WC, Larson EB: Neuropsychological test performance in a cognitively intact sample of older Japanese American adults. Arch Clin Neuropsychol 2001;16: 447-459.
19. Fillenbaum GG, Huber M, Taussig IM: Performance of elderly White and African-American community residents on the abbreviated CERAD Boston Naming Test. J Clin Exp Neuropsychol 1997;19:204-210.
20. Manly JJ, Jacobs DM, Sano M, Bell K, Merchant CA, Small SA, Stern Y: Cognitive test performance among nondemented elderly African-Americans and Whites. Neurology 1998;50:1238-1245.
21. Jacobs DM, Sano M, Albert S, Schofield P, Dooneief G, Stern Y: Cross-cultural neuropsychological assessment: a comparison of randomly selected, demographically matched cohorts of English- and Spanish-speaking older adults. J Clin Exp Neuropsychol 1997;19:331-339.
22. Lucas JA, Ivnik RJ, Smith GE, Ferman TJ, Willis FB, Petersen RC, Graff-Radford NR: Mayo's Older African-Americans Normative Studies: norms for Boston Naming Test, Controlled Oral Word Association, Category Fluency, Animal Naming, Token Test, WRAT-3 Reading, Trail Making Test, Stroop Test, and Judgment of Line Orientation. Clin Neuropsychol 2005;19:243-269.
23. Seo EH, Lee DY, Kim KW, Lee JH, Jhoo JH, Youn JC, Choo IH, Ha J, Woo JI: A normative study of the Trail Making Test in Korean elders. Int J Geriatr Psychiatry 2006;21:844- 852.
24. Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R: Predictive utility of Apolipoprotein E genotype for Alzheimer's disease in outpatients with mild cognitive impairment. Arch Neurol 2005;62: 975-980.